249 related articles for article (PubMed ID: 31784650)
1. The microcosmos of intratumor heterogeneity: the space-time of cancer evolution.
Janiszewska M
Oncogene; 2020 Mar; 39(10):2031-2039. PubMed ID: 31784650
[TBL] [Abstract][Full Text] [Related]
2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
3. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.
Vessoni AT; Filippi-Chiela EC; Lenz G; Batista LFZ
Oncogene; 2020 Mar; 39(10):2055-2068. PubMed ID: 31801972
[TBL] [Abstract][Full Text] [Related]
4. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
[TBL] [Abstract][Full Text] [Related]
5. Translational implications of tumor heterogeneity.
Jamal-Hanjani M; Quezada SA; Larkin J; Swanton C
Clin Cancer Res; 2015 Mar; 21(6):1258-66. PubMed ID: 25770293
[TBL] [Abstract][Full Text] [Related]
6. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.
McGranahan N; Swanton C
Cancer Cell; 2015 Jan; 27(1):15-26. PubMed ID: 25584892
[TBL] [Abstract][Full Text] [Related]
7. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
8. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
9. Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome.
Venkatesan S; Swanton C
Am Soc Clin Oncol Educ Book; 2016; 35():e141-9. PubMed ID: 27249716
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
[TBL] [Abstract][Full Text] [Related]
11. The challenges of tumor genetic diversity.
Mroz EA; Rocco JW
Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
[TBL] [Abstract][Full Text] [Related]
12. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
13. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
[TBL] [Abstract][Full Text] [Related]
14. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
Marusyk A; Janiszewska M; Polyak K
Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
[TBL] [Abstract][Full Text] [Related]
15. Cancer as an ecomolecular disease and a neoplastic consortium.
Ramón Y Cajal S; Capdevila C; Hernandez-Losa J; De Mattos-Arruda L; Ghosh A; Lorent J; Larsson O; Aasen T; Postovit LM; Topisirovic I
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):484-499. PubMed ID: 28947238
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic heterogeneity in cancer.
Guo M; Peng Y; Gao A; Du C; Herman JG
Biomark Res; 2019; 7():23. PubMed ID: 31695915
[TBL] [Abstract][Full Text] [Related]
17. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
18. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
Campoy EM; Branham MT; Mayorga LS; Roqué M
BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
[TBL] [Abstract][Full Text] [Related]
19. Intratumor heterogeneity in epigenetic patterns.
Assenov Y; Brocks D; Gerhäuser C
Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
